Agreed
There is enough evidence to apply for an Australia Medicare code and that has been mentioned before.
As below there is an outsized benefit to the NSW Health system and not enough to IPD.
It's not clear if below covers all cancers or just BCRL - but if only for BCRL then avoided health costs will increase even more.
As part of the strategic review I expect this is been looked at and will be compared against all the other possible revenue generators.
September is not far away.
there is a better way.
Acclivity
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report and Appendix 4C - Jun-2024 Qtr
AgreedThere is enough evidence to apply for an Australia...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $111.2M |
Open | High | Low | Value | Volume |
5.7¢ | 5.7¢ | 5.4¢ | $43.81K | 805.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 333033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 0.052 |
1 | 500000 | 0.051 |
5 | 190000 | 0.050 |
2 | 77732 | 0.049 |
1 | 27812 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 333033 | 2 |
0.056 | 1005 | 1 |
0.057 | 250000 | 1 |
0.058 | 29118 | 2 |
0.059 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online